Acasti Pharma to Acquire Indian Origin Emerging Biopharmaceutical Grace Therapeutics

Acasti will acquire Grace's 'pipeline of rare and orphan disease programs, including 3 clinical stage assets that have received Orphan Drug Designation from the US Food & Drug Administration,' the company said.

from Top Business News- News18.com
Read The Rest:timesnownews...